JP2016539148A5 - - Google Patents

Download PDF

Info

Publication number
JP2016539148A5
JP2016539148A5 JP2016536528A JP2016536528A JP2016539148A5 JP 2016539148 A5 JP2016539148 A5 JP 2016539148A5 JP 2016536528 A JP2016536528 A JP 2016536528A JP 2016536528 A JP2016536528 A JP 2016536528A JP 2016539148 A5 JP2016539148 A5 JP 2016539148A5
Authority
JP
Japan
Prior art keywords
alkyl
group
optionally substituted
phenyl
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016536528A
Other languages
English (en)
Japanese (ja)
Other versions
JP6457523B2 (ja
JP2016539148A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2014/075890 external-priority patent/WO2015082324A1/en
Publication of JP2016539148A publication Critical patent/JP2016539148A/ja
Publication of JP2016539148A5 publication Critical patent/JP2016539148A5/ja
Application granted granted Critical
Publication of JP6457523B2 publication Critical patent/JP6457523B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016536528A 2013-12-04 2014-11-28 医薬組成物のためのスルホキシイミン置換キナゾリン Expired - Fee Related JP6457523B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13195720 2013-12-04
EP13195720.1 2013-12-04
PCT/EP2014/075890 WO2015082324A1 (en) 2013-12-04 2014-11-28 Sulfoximine substituted quinazolines for pharmaceutical compositions

Publications (3)

Publication Number Publication Date
JP2016539148A JP2016539148A (ja) 2016-12-15
JP2016539148A5 true JP2016539148A5 (enExample) 2017-11-30
JP6457523B2 JP6457523B2 (ja) 2019-01-23

Family

ID=49726564

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016536528A Expired - Fee Related JP6457523B2 (ja) 2013-12-04 2014-11-28 医薬組成物のためのスルホキシイミン置換キナゾリン

Country Status (7)

Country Link
US (1) US10093660B2 (enExample)
EP (1) EP3077383B1 (enExample)
JP (1) JP6457523B2 (enExample)
AU (1) AU2014359456B2 (enExample)
CA (1) CA2929742C (enExample)
ES (1) ES2693520T3 (enExample)
WO (1) WO2015082324A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6479854B2 (ja) * 2014-05-07 2019-03-06 エヴォテック・インターナショナル・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングEvotec International GmbH 医薬組成物のためのスルホキシイミン置換キナゾリン
UY38540A (es) * 2019-01-14 2020-08-31 Pi Industries Ltd Compuestos de fenilamidina 3-sustituida, preparación y uso
CN112812136B (zh) * 2019-11-15 2022-04-12 武汉光谷亚太医药研究院有限公司 新型2,3-二氢化茚衍生化合物、制备方法和应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3987192A (en) 1974-01-07 1976-10-19 The Upjohn Company Compositions and process of treatment
US5602118A (en) 1993-03-16 1997-02-11 American Cyanamid Company 2-thiosubstituted carbapenems
EP0765324A1 (en) 1994-06-08 1997-04-02 E.I. Du Pont De Nemours And Company Cyclic sulfonamide herbicides
SE0102147D0 (sv) 2001-06-18 2001-06-18 Pharmacia Ab New methods
DK1439863T3 (da) 2001-10-29 2011-03-14 Boehringer Ingelheim Int MNK-kinase-homologe proteiner, som er involveret i reguleringen af energihomeostase og organelmetabolisme
JP2005527511A (ja) 2002-03-01 2005-09-15 ファイザー インコーポレイテッド 抗血管形成剤として有用なチエノピリジンのインドリル−尿素誘導体およびその使用法
GB0315587D0 (en) 2003-07-03 2003-08-13 Univ Dundee Anti-inflammatory assay and compounds
US7678920B2 (en) 2004-04-08 2010-03-16 Dow Agrosciences Llc Insecticidal N-substituted sulfoximines
EP1746099A1 (en) 2004-12-23 2007-01-24 DeveloGen Aktiengesellschaft Mnk1 or Mnk2 inhibitors
EP1899353A1 (en) * 2005-06-22 2008-03-19 DeveloGen Aktiengesellschaft Thienopyrimidines for pharmaceutical compositions
CA2646429A1 (en) 2006-03-09 2007-09-13 Pharmacopeia, Inc. 8-heteroarylpurine mnk2 inhibitors for treating metabolic disorders
EA200802118A1 (ru) * 2006-04-07 2009-04-28 Девелоджен Ациенгезельшафт Обладающие ингибирующей активностью в отношении mnk1/mnk2 тиенопиримидины, предназначенные для применения в фармацевтических композициях
DE602007004618D1 (de) 2006-06-22 2010-03-18 Biovitrum Ab Publ Pyridin- und pyrazinderivate als mnk-kinaseinhibitoren
WO2008141843A1 (en) * 2007-05-24 2008-11-27 Bayer Schering Pharma Aktiengesellschaft Novel sulphoximine-substituted quinazoline and quinazoline derivatives as kinase inhibitors
DE102007024470A1 (de) 2007-05-24 2008-11-27 Bayer Schering Pharma Aktiengesellschaft Neue Sulfoximin-substituierte Chinolin- bzw. Chinazolinderivate als Kinase-Inhibitoren
JP2011510033A (ja) 2008-01-25 2011-03-31 シンジェンタ パーティシペーションズ アクチェンゲゼルシャフト 化合物
EP2504010A4 (en) 2009-11-23 2013-04-17 Merck Sharp & Dohme Fused Bicyclic Pyrimidine Derivatives and Methods of Use Therefor
UY33241A (es) * 2010-02-26 2011-09-30 Boehringer Ingelheim Int ?Tienopirimidinas que contienen heterocicloalquilo para composiciones farmacéuticas?.
AR080328A1 (es) 2010-02-26 2012-03-28 Boehringer Ingelheim Int Tienopirimidinas que contienen un grupo alquilo sustituido inhibidoras de quinasas mnk1 y/o mnk2, composiciones farmaceuticas que las contienen y uso de las mismas para el tratamiento de trastornos metabolicos tales como diabetes y obesidad, y trastornos hiperproliferativos, entre otros
AR088082A1 (es) 2011-10-13 2014-05-07 Lilly Co Eli Moduladores selectivos del receptor androgeno
WO2014072244A1 (en) 2012-11-09 2014-05-15 Boehringer Ingelheim International Gmbh Sulfoximine substituted quinazolines for pharmaceutical compositions
ES2663788T3 (es) * 2013-06-28 2018-04-17 Evotec International Gmbh Quinazolinas sustituidas con sulfoximina y su uso como inhibidores de MNK1 y/o MNK2 quinasas

Similar Documents

Publication Publication Date Title
JP2016515561A5 (enExample)
JP2013518107A5 (enExample)
JP2013542247A5 (enExample)
JP2016510326A5 (enExample)
JP2015508103A5 (enExample)
JP2014532647A5 (enExample)
JP2015511609A5 (enExample)
JP2014511891A5 (enExample)
JP2016503797A5 (enExample)
RU2016141569A (ru) Комбинации
JP2017517538A5 (enExample)
HK1210771A1 (zh) 氮杂吲哚衍生物
JP2015509075A5 (enExample)
JP2017518360A5 (enExample)
JP2013518036A5 (enExample)
JP2012522841A5 (enExample)
JP2018525425A5 (enExample)
JP2015516419A5 (enExample)
JP2016515550A5 (enExample)
BR112015016184A2 (pt) derivados de piridona e seu uso no tratamento, melhora ou prevenção de uma doença viral
JP2014528464A5 (enExample)
RU2015135824A (ru) Бициклические соединения пиримидона в качестве ингибиторов lp-pla2
JP2016539148A5 (enExample)
JP2016516691A5 (enExample)
JP2021503451A5 (enExample)